Pseudoginsenoside F11, a novel partial PPAR γ agonist, promotes adiponectin oligomerization and secretion in 3T3-L1 adipocytes

PPAR Research

Volumn , Issue , 2013, Pages

  Wu, Guoyu ^a   Yi, Junyang ^a   Liu, Ling ^a   Wang, Pengcheng ^a   Zhang, Zhijie ^b   Li, Zhen ^a  

^a TSINGHUA UNIVERSITY   (China)

^b INSTITUTE OF CHINESE MATERIA MEDICA   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84893854590     PISSN: 16874757     EISSN: 16874765     Source Type: Journal    
DOI: 10.1155/2013/701017     Document Type: Article

References (46)

1. Ahmadian M., Suh J. M., Hah N., PPAR γ signaling and metabolism: the good, the bad and the future. Nature Medicine 2013 19 5 557 566 10.1038/nm.3159
2. Lehrke M., Lazar M. A., The many faces of PPARgamma. Cell 2005 123 6 993 999 2-s2.0-28944446431 10.1016/j.cell.2005.11.026 (Pubitemid 41785415)
3. Willson T. M., Lambert M. H., Kliewer S. A., Peroxisome proliferator-activated receptor γ and metabolic disease. Annual Review of Biochemistry 2001 70 341 367 2-s2.0-0034923501 10.1146/annurev.biochem.70.1.341 (Pubitemid 32662214)
4. Nagy L., Schwabe J., Mechanism of the nuclear receptor molecular switch. Trends in Biochemical Sciences 2004 29 6 317 324 2-s2.0-3242784885 10.1016/j.tibs.2004.04.006 (Pubitemid 38968764)
5. Glass C. K., Rosenfeld M. G., The coregulator exchange in transcriptional functions of nuclear receptors. Genes & Development 2000 14 2 121 141 2-s2.0-0034650893 10.1101/gad.14.2.121 (Pubitemid 30070977)
6. Lehmann J. M., Moore L. B., Smith-Oliver T. A., Wilkison W. O., Willson T. M., Kliewer S. A., An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPAR γ). The Journal of Biological Chemistry 1995 270 22 12953 12956 2-s2.0-0029016829 10.1074/jbc.270.22.12953
7. Defronzo R. A., Banting Lecture. from the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus. Diabetes 2009 58 4 773 795 2-s2.0-64649104158 10.2337/db09-9028
8. Blazer-Yost B. L., PPARgamma agonists: blood pressure and edema. PPAR Research 2010 2010 5 785369 10.1155/2010/785369
9. Mamtani R., Haynes K., Bilker W. B., Association between longer therapy with thiazolidinediones and risk of bladder cancer: a cohort study. Journal of the National Cancer Institute 2012 104 18 1411 1421 10.1093/jnci/djs328
10. Jones D., Potential remains for PPAR-targeted drugs. Nature Reviews Drug Discovery 2010 9 9 668 669 2-s2.0-77956335013 10.1038/nrd3271
11. Choi J. H., Banks A. S., Estall J. L., Kajimura S., Boström P., Laznik D., Ruas J. L., Chalmers M. J., Kamenecka T. M., Blüher M., Griffin P. R., Spiegelman B. M., Anti-diabetic drugs inhibit obesity-linked phosphorylation of PPAR γ by Cdk5. Nature 2010 466 7305 451 456 2-s2.0-77954941113 10.1038/nature09291
12. Amato A. A., Rajagopalan S., Lin J. Z., GQ-16, a novel peroxisome proliferator-activated receptor γ (PPAR γ) ligand, promotes insulin sensitization without weight gain. The Journal of Biological Chemistry 2012 287 33 28169 28179 10.1074/jbc.M111.332106
13. Choi J. H., Banks A. S., Kamenecka T. M., Busby S. A., Chalmers M. J., Kumar N., Kuruvilla D. S., Shin Y., He Y., Bruning J. B., Marciano D. P., Cameron M. D., Laznik D., Jurczak M. J., Schürer S. C., Vidović D., Shulman G. I., Spiegelman B. M., Griffin P. R., Antidiabetic actions of a non-agonist PPAR γ ligand blocking Cdk5-mediated phosphorylation. Nature 2011 477 7365 477 481 2-s2.0-80053131732 10.1038/nature10383
14. Weidner C., de Groot J. C., Prasad A., Amorfrutins are potent antidiabetic dietary natural products. Proceedings of the National Academy of Sciences of the United States of America 2012 109 19 7257 7262 10.1073/pnas.1116971109
15. Lee D. H., Huang H., Choi K., Mantzoros C., Kim Y.-B., Selective PPAR γ modulator INT131 normalizes insulin signaling defects and improves bone mass in diet-induced obese mice. American Journal of Physiology-Endocrinology and Metabolism 2012 302 5 E552 E560 2-s2.0-84857351107 10.1152/ajpendo.00569. 2011
16. Chandalia A., Clarke H. J., Clemens L. E., Gregoire F. M., Pandey B., Vicena V., Lee P., Lavan B. E., MBX-102/JNJ39659100, a novel non-TZD selective partial PPAR- γ agonist lowers triglyceride independently of PPAR- α activation. PPAR Research 2009 2009 12 2-s2.0-65649104489 10.1155/2009/706852 706852
17. Waki H., Yamauchi T., Kamon J., Ito Y., Uchida S., Kita S., Hara K., Hada Y., Vasseur F., Froguel P., Kimura S., Nagai R., Kadowaki T., Impaired multimerization of human adiponectin mutants associated with diabetes-molecular structure and multimer formation of adiponectin. The Journal of Biological Chemistry 2003 278 41 40352 40363 2-s2.0-0141924849 10.1074/jbc.M300365200 (Pubitemid 37248604)
18. Tsao T.-S., Tomas E., Murrey H. E., Hug C., Lee D. H., Ruderman N. B., Heuser J. E., Lodish H. F., Role of disulfide bonds in Acrp30/adiponectin structure and signaling specificity-different oligomers activate different signal transduction pathways. The Journal of Biological Chemistry 2003 278 50 50810 50817 2-s2.0-0347379841 10.1074/jbc.M309469200 (Pubitemid 37548930)
19. Pajvani U. B., Hawkins M., Combs T. P., Rajala M. W., Doebber T., Berger J. P., Wagner J. A., Wu M., Knopps A., Xiang A. H., Utzschneider K. M., Kahn S. E., Olefsky J. M., Buchanan T. A., Scherer P. E., Complex distribution, not absolute amount of adiponectin, correlates with thiazolidinedione-mediated improvement in insulin sensitivity. The Journal of Biological Chemistry 2004 279 13 12152 12162 2-s2.0-11144355637 10.1074/jbc.M311113200 (Pubitemid 38445780)
20. Wang Y., Yau M.-H., Xu A. M., Lam K. S. L., Post-translational modifications of adiponectin: mechanisms and functional implications. Biochemical Journal 2008 409 3 623 633 2-s2.0-38949125405 10.1042/BJ20071492 (Pubitemid 351214189)
21. Yamauchi T., Kadowaki T., Adiponectin receptor as a key player in healthy longevity and obesity-related diseases. Cell Metabolism 2013 17 2 185 196 10.1016/j.cmet.2013.01.001
22. Arita Y., Kihara S., Ouchi N., Takahashi M., Maeda K., Miyagawa J.-I., Hotta K., Shimomura I., Nakamura T., Miyaoka K., Kuriyama H., Nishida M., Yamashita S., Okubo K., Matsubara K., Muraguchi M., Ohmoto Y., Funahashi T., Matsuzawa Y., Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochemical and Biophysical Research Communications 1999 257 1 79 83 2-s2.0-0033515761 10.1006/bbrc.1999.0255 (Pubitemid 29299050)
23. Hotta K., Funahashi T., Arita Y., Takahashi M., Matsuda M., Okamoto Y., Iwahashi H., Kuriyama H., Ouchi N., Maeda K., Nishida M., Kihara S., Sakai N., Nakajima T., Hasegawa K., Muraguchi M., Ohmoto Y., Nakamura T., Yamashita S., Hanafusa T., Matsuzawa Y., Plasma concentrations of a novel, adipose-specific protein, adiponectin, in type 2 diabetic patients. Arteriosclerosis, Thrombosis, and Vascular Biology 2000 20 6 1595 1599 2-s2.0-0034096988 (Pubitemid 30353893)
24. Bobbert T., Rochlitz H., Wegewitz U., Akpulat S., Mai K., Weickert M. O., Möhlig M., Pfeiffer A. F. H., Spranger J., Changes of adiponectin oligomer composition by moderate weight reduction. Diabetes 2005 54 9 2712 2719 2-s2.0-24144453059 10.2337/diabetes.54.9.2712 (Pubitemid 41233594)
25. Combs T. P., Berg A. H., Rajala M. W., Klebanov S., Iyengar P., Jimenez-Chillaron J. C., Patti M. E., Klein S. L., Weinstein R. S., Scherer P. E., Sexual differentiation, pregnancy, calorie restriction, and aging affect the adipocyte-specific secretory protein adiponectin. Diabetes 2003 52 2 268 276 2-s2.0-0037317488 10.2337/diabetes.52.2.268 (Pubitemid 36173178)
26. Maeda N., Takahashi M., Funahashi T., Kihara S., Nishizawa H., Kishida K., Nagaretani H., Matsuda M., Komuro R., Ouchi N., Kuriyama H., Hotta K., Nakamura T., Shimomura I., Matsuzawa Y., PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 2001 50 9 2094 2099 2-s2.0-0035462629 (Pubitemid 33643677)
27. Tishinsky J. M., Dyck D. J., Robinson L. E., Lifestyle factors increasing adiponectin synthesis and secretion. Vitamins and Hormones 2012 90 1 30 10.1016/B978-0-12-398313-8.00001-4
28. Iwaki M., Matsuda M., Maeda N., Funahashi T., Matsuzawa Y., Makishima M., Shimomura I., Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors. Diabetes 2003 52 7 1655 1663 2-s2.0-0037677767 10.2337/diabetes.52.7.1655 (Pubitemid 36792453)
29. Liu M., Zhou L., Xu A., Lam K. S. L., Wetzel M. D., Xiang R., Zhang J., Xin X., Dong L. Q., Liu F., A disulfide-bond A oxidoreductase-like protein (DsbA-L) regulates adiponectin multimerization. Proceedings of the National Academy of Sciences of the United States of America 2008 105 47 18302 18307 2-s2.0-57449111690 10.1073/pnas.0806341105
30. Qiang L., Wang H., Farmer S. R., Adiponectin secretion is regulated by SIRT1 and the endoplasmic reticulum oxidoreductase ero1-1 alpha. Molecular and Cellular Biology 2007 27 13 4698 4707 2-s2.0-34347338702 10.1128/MCB.02279-06 (Pubitemid 47016124)
31. Yu R.-M., Jin Q.-X., Sun H., Ye W.-C., Zhao Y., The growth characteristics and ginsenosides isolation of suspension-cultured crown gall of Panax quinquefolium. Chinese Journal of Biotechnology 2005 21 5 754 758 2-s2.0-38349073226
32. Chan T. W., But P. P., Cheng S. W., Kwok I. M. Y., Lau F. W., Xu H. X., Differentiation and authentication of Panax ginseng, Panax quinquefolius, and ginseng products by using HPLC/MS. Analytical Chemistry 2000 72 6 1281 1287 2-s2.0-0034654608 10.1021/ac990819z (Pubitemid 30163787)
33. Li W., Gu C., Zhang H., Awang D. V. C., Fitzloff J. F., Fong H. H. S., Van Breemen R. B., Use of high-performance liquid chromatography-tandem mass spectrometry to distinguish Panax ginseng C. A. Meyer (Asian ginseng) and Panax quinquefolius L. (North American ginseng). Analytical Chemistry 2000 72 21 5417 5422 2-s2.0-0034329658 10.1021/ac000650l
34. Li Z., Wu C. F., Pei G., Guo Y. Y., Li X., Antagonistic effect of pseudoginsenoside-F11 on the behavioral actions of morphine in mice. Pharmacology Biochemistry and Behavior 2000 66 3 595 601 2-s2.0-0033934591 10.1016/S0091-3057(00)00260-4 (Pubitemid 30440856)
35. Hao Y., Yang J. Y., Wu C. F., Wu M. F., Pseudoginsenoside-F11 decreases morphine-induced behavioral sensitization and extracellular glutamate levels in the medial prefrontal cortex in mice. Pharmacology Biochemistry and Behavior 2007 86 4 660 666 2-s2.0-34249712470 10.1016/j.pbb.2007.02.011 (Pubitemid 46829319)
36. Li Z., Guo Y. Y., Wu C. F., Li X., Wang J. H., Protective effects of pseudoginsenoside-F11 on scopolamine-induced memory impairment in mice and rats. Journal of Pharmacy and Pharmacology 1999 51 4 435 440 2-s2.0-0033035270 10.1211/0022357991772484 (Pubitemid 29248320)
37. Wu C. F., Liu Y. L., Song M., Liu W., Wang J. H., Li X., Yang J. Y., Protective effects of pseudoginsenoside-F11 on methamphetamine-induced neurotoxicity in mice. Pharmacology Biochemistry and Behavior 2003 76 1 103 109 2-s2.0-1642378970 10.1016/S0091-3057(03)00215-6 (Pubitemid 38366172)
38. Wang C. M., Liu M. Y., Wang F., Anti-amnesic effect of pseudoginsenoside-F11 in two mouse models of Alzheimer's disease. Pharmacology Biochemistry and Behavior 2013 106 57 67 10.1016/j.pbb.2013.03.010
39. Li Y., Wang P. C., Zhuang Y., Lin H., Li Y., Liu L., Meng Q., Cui T., Liu J., Li Z., Activation of AMPK by berberine promotes adiponectin multimerization in 3T3-L1 adipocytes. FEBS Letters 2011 585 12 1735 1740 2-s2.0-79958116611 10.1016/j.febslet.2011.04.051
40. Chen Z. F., Zhang L., Yi J. Y., Promotion of adiponectin multimerization by emodin: a novel AMPK activator with PPAR γ -agonist activity. Journal of Cellular Biochemistry 2012 113 11 3547 3558 10.1002/jcb.24232
41. Tontonoz P., Hu E. D., Spiegelman B. M., Stimulation of adipogenesis in fibroblasts by PPAR γ 2, a lipid-activated transcription factor. Cell 1994 79 7 1147 1156 2-s2.0-0028641559
42. Gampe R. T. Jr., Montana V. G., Lambert M. H., Miller A. B., Bledsoe R. K., Milburn M. V., Kliewer S. A., Willson T. M., Xu H. E., Asymmetry in the PPARgamma/RXRalpha crystal structure reveals the molecular basis of heterodimerization among nuclear receptors. Molecular Cell 2000 5 3 545 555 2-s2.0-0033681001
43. Motani A., Wang Z., Weiszmann J., McGee L. R., Lee G., Liu Q., Staunton J., Fang Z., Fuentes H., Lindstrom M., Liu J., Biermann D. H. T., Jaen J., Walker N. P. C., Learned R. M., Chen J.-L., Li Y., INT131: a selective modulator of PPAR gamma. Journal of Molecular Biology 2009 386 5 1301 1311 2-s2.0-60849095073 10.1016/j.jmb.2009.01.025
44. Floyd Z. E., Stephens J. M., Controlling a master switch of adipocyte development and insulin sensitivity: covalent modifications of PPAR γ Biochimica et Biophysica Acta 2012 1822 7 1090 1095 2-s2.0-84860284206 10.1016/j.bbadis.2012.03.014
45. Whitehead J. P., Diabetes: new conductors for the peroxisome proliferator-activated receptor γ (PPAR γ) orchestra. The International Journal of Biochemistry & Cell Biology 2011 43 8 1071 1074 2-s2.0-79958717870 10.1016/j.biocel.2011.04.017
46. Mucalo I., Rahelic D., Jovanovski E., Effect of American ginseng (Panax quinquefolius L.) on glycemic control in type 2 diabetes. Collegium Antropologicum 2012 36 4 1435 1440